NCT03423082View on ClinicalTrials.gov

Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions
Cervical CancerUterine Cancer
Interventions
DRUG

18F fluciclovine

Each subject will receive one IV dose of 18F fluciclovine for PET scanning

DEVICE

18F fluciclovine PET

Each subject will undergo one 18F fluciclovine PET scan on a hybrid PET/MRI scanner

Trial Locations (1)

15213

UPMC Presbyterian - MR Research Center, Pittsburgh

Sponsors

Collaborators (1)

Blue Earth Diagnostics
All Listed Sponsors
collaborator

Blue Earth Diagnostics

INDUSTRY

lead

Nghi Nguyen

OTHER

NCT03423082 - Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. | Biotech Hunter | Biotech Hunter